<DOC>
	<DOCNO>NCT02238717</DOCNO>
	<brief_summary>This study examine activity 2 different dos PF-06372865 panel evoke pain test carry 0.5 10 hour follow oral dose healthy male subject .</brief_summary>
	<brief_title>Assessment Analgesic Effects PF-06372865 Healthy Volunteers Using Evoked Pain Endpoints</brief_title>
	<detailed_description />
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Healthy male subject age 18 55 year , inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Evidence personally sign date informed consent document indicate subject inform pertinent aspect study . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Any condition possibly affect drug absorption ( eg , gastrectomy ) . A positive urine drug screen .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Pain</keyword>
	<keyword>evoke pain</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>pharmacodynamics</keyword>
</DOC>